Atlas Trials

The Efficacy and Safety of Benmelstobart for GC/EGC

Clinical trial NCT06603974 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06603974
Sponsor
Xijing Hospital
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Gastric Cancer
Start date
2024-10-16
Primary completion
2026-07-26
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.